Drug Profile
Alprostadil - Taiwan Liposome Company
Alternative Names: Alprostadil nanoemulsion - Taiwan Liposome Company; PGE1 - Taiwan Liposome Company; ProFlow; Prostaglandin E1 - Taiwan Liposome CompanyLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Taiwan Liposome Company
- Class Erectile dysfunction therapies; Monounsaturated fatty acids; Muscle relaxants; Peripheral vasodilators; Prostaglandins; Small molecules
- Mechanism of Action Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diabetic foot ulcer; Diabetic neuropathies; Peripheral arterial disorders
Most Recent Events
- 27 Jun 2019 Chemical structure information added
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Diabetic-foot-ulcer in China (IV, Controlled release)
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Diabetic-foot-ulcer in Japan (IV, Controlled release)